LEADER 02243nam  2200445   450 
001 9910317675503321
005 20231214145426.0
010   $a953-51-5473-7
010   $a953-51-2982-1
035   $a(CKB)4970000000099329
035   $a(iGPub)INOP0003191
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/48151
035   $a(EXLCZ)994970000000099329
100   $a20200213017    xx  c0             0
101 0 $aeng
135   $aurcn#|||m|||a
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFrontiers in Staphylococcus aureus
210   $cIntechOpen$d2017
210  1$a[Place of publication not identified] :$cIntechOpen,$d2017.
210  4$dİ2017
215   $a1 online resource (236 pages)
311   $a953-51-2981-3 
330   $a<i>Staphylococcus</i> was first recognized as a human pathogen in 1880 and was named for its grape cluster-like appearance. In 1884, <i>Staphylococcus aureus</i> was identified and named for its vibrant golden color, which was later found to be the result of golden toxin production. Here, experts examine in-depth patterns of <i>S. aureus</i> colonization and exposures in humans, mammals, and birds that have led to the development of various clinical diseases. The mode of transmission of <i>S. aureus</i> and different methods for its detection in different samples are defined. Conventional antibiotic options to treat this aggressive, multifaceted, and readily adaptable pathogen are becoming limited. Alternative, novel chemotherapeutics to target <i>S. aureus</i> are discussed in the pages within, including herbal medicines, bee products, and modes of delivery.
517   $aFrontiers in Staphylococcus aureus
606   $aSCIENCE / Life Sciences / Bacteriology$2bisacsh
610   $aLife Sciences
610   $aPure Microbiology
610   $aImmunology and Microbiology
610   $aBacteriology
615  7$aSCIENCE / Life Sciences / Bacteriology.
700   $aShymaa Enany$4auth$01329506
702   $aEnany$b Shymaa
702   $aAlexander$b Laura E. Crotty
906   $aBOOK
912   $a9910317675503321
996   $aFrontiers in Staphylococcus aureus$93039527
997   $aUNINA